Cedar Hill Associates LLC trimmed its stake in CME Group Inc (NASDAQ:CME) by 13.1% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 50,422 shares of the financial services provider’s stock after selling 7,575 shares during the quarter. CME Group makes up 1.7% of Cedar Hill Associates LLC’s holdings, making the stock its 19th largest holding. Cedar Hill Associates LLC’s holdings in CME Group were worth $8,265,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. USS Investment Management Ltd grew its holdings in shares of CME Group by 642.7% during the first quarter. USS Investment Management Ltd now owns 1,212,042 shares of the financial services provider’s stock valued at $191,115,000 after buying an additional 1,048,842 shares in the last quarter. Unigestion Holding SA purchased a new position in shares of CME Group during the second quarter valued at $96,251,000. Westfield Capital Management Co. LP grew its holdings in shares of CME Group by 777.5% during the first quarter. Westfield Capital Management Co. LP now owns 610,726 shares of the financial services provider’s stock valued at $98,779,000 after buying an additional 541,126 shares in the last quarter. Epoch Investment Partners Inc. grew its holdings in shares of CME Group by 51.9% during the first quarter. Epoch Investment Partners Inc. now owns 1,545,562 shares of the financial services provider’s stock valued at $249,980,000 after buying an additional 528,198 shares in the last quarter. Finally, KAMES CAPITAL plc purchased a new position in shares of CME Group during the second quarter valued at $85,187,000. Institutional investors and hedge funds own 82.57% of the company’s stock.

In other CME Group news, Director Ronald A. Pankau sold 250 shares of the business’s stock in a transaction dated Thursday, June 7th. The stock was sold at an average price of $171.51, for a total value of $42,877.50. Following the transaction, the director now owns 3,559 shares in the company, valued at $610,404.09. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Martin J. Gepsman sold 600 shares of the business’s stock in a transaction dated Friday, May 25th. The shares were sold at an average price of $159.77, for a total value of $95,862.00. Following the completion of the transaction, the director now owns 42,411 shares in the company, valued at approximately $6,776,005.47. The disclosure for this sale can be found here. Insiders sold 44,654 shares of company stock worth $7,234,893 in the last 90 days. Corporate insiders own 0.57% of the company’s stock.

A number of brokerages have recently weighed in on CME. Compass Point began coverage on CME Group in a report on Monday, July 9th. They set a “neutral” rating and a $170.00 price target on the stock. BidaskClub downgraded CME Group from a “buy” rating to a “hold” rating in a report on Tuesday, July 10th. Wells Fargo & Co lifted their price target on CME Group from $170.00 to $175.00 and gave the company a “market perform” rating in a report on Monday, July 9th. Finally, Zacks Investment Research downgraded CME Group from a “buy” rating to a “hold” rating in a report on Tuesday, June 5th. Six research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. CME Group has a consensus rating of “Buy” and a consensus price target of $170.29.

Shares of NASDAQ CME opened at $162.97 on Friday. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.15. CME Group Inc has a one year low of $123.05 and a one year high of $174.36. The stock has a market capitalization of $55.47 billion, a price-to-earnings ratio of 27.65, a PEG ratio of 3.06 and a beta of 0.64.

CME Group (NASDAQ:CME) last issued its earnings results on Thursday, July 26th. The financial services provider reported $1.74 EPS for the quarter, beating analysts’ consensus estimates of $1.72 by $0.02. CME Group had a return on equity of 9.03% and a net margin of 111.45%. The firm had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter in the previous year, the company posted $1.22 earnings per share. The business’s quarterly revenue was up 14.6% compared to the same quarter last year. equities research analysts anticipate that CME Group Inc will post 6.68 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 25th. Shareholders of record on Monday, September 10th will be paid a $0.70 dividend. This represents a $2.80 dividend on an annualized basis and a yield of 1.72%. CME Group’s dividend payout ratio (DPR) is currently 58.70%.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Featured Story: Outstanding Shares, Buying and Selling Stocks

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.